Science News

Drug Banned By Sports May Be Good For Oldies

ScienceDaily (June 14, 2006) — A world-first pilot study suggests that anabolic steroids, best known for doping in sports, may in fact help older people recover better after joint replacement surgery.

Associate Professor Erik Hohmann hopes to extend the initial pilot into a larger study after finding benefits for recuperating patients, even though only low doses of the drug were used to avoid side effects.

Benefits identified already include better muscle strength, mobility and bone mineral density.

Associate Professor Hohmann said joint replacement is an increasingly common operation for the 60+ set (it's the main treatment for end-stageosteo-arthritis) as populations are aging.

"It seems we can build muscle and bone density faster and this helps the patients mobilise faster, which in turn improves their general overall health," he said.

The researcher is Director of the Musculoskleletal Research Unit at Central Queensland University. The research is in collaboration with the Department of Orthopaedics at Rockhampton Hospital.


Adapted from materials provided by Central Queensland University.
Email or share this story:
| More
APA

MLA

Search ScienceDaily

Number of stories in archives: 77,281

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily's archives for related news topics,
the latest news stories, reference articles, science videos, images, and books.
 

Science Video News


Patients Go Wireless For Faster Recovery

Surgeons provide recent joint replacement patients with transmitters to wirelessly send blood pressure, pulse/oxygen, and breathing data to staff.. ...  > full story

Breaking News

... from NewsDaily.com

In Other News ...

Copyright Reuters 2008. See Restrictions.

Free Subscriptions

... from ScienceDaily

Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Feedback

... we want to hear from you!

Tell us what you think of the new ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Post this page to your favorite social bookmarking site:
close
Include this item in your blog or web site:
close
Cite this article in your essay, paper, or report:
close
Email this page's link to a friend or colleague:
close